Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on May 19, 2021 11:54am
87 Views
Post# 33230207

RE:News!!!

RE:News!!!

As mentioned the other day, take one country, Kenya, and based on their own projections they could be at least two to three years vaccinating the whole of the country. Multiply that by x no. of countries still struggling to get life in order and thus the need for tests appears staggering.

No one has a crystal ball but if the need remains over that timeframe and THRM can participate in a fraction of this, the revenue generated "could" also be staggering.

There are already complaints surfacing that the Abbott tests currently selling over the counter in Canada are too expensive at $.40. Should THRM be able to scale up production of AcuVid to the point that kits can sell for $10 (as Rob mentioned in his interview) they may eventually usurp tests already being considered and/or being sold across a number of jurisdictions.

The potential is overwhelming to consider.

GLTE!!!


Smokey1958 wrote:

Paragraph from Malaysian NR on the agreement.

"However, it said with manufacturing anticipated to commence in the third quarter of 2021 and forecast sales progressively scaling up to an estimated one million kits per month during the two year period...

https://www.malaymail.com/news/money/2021/05/19/k-one-techs-unit-enters-development-and-manufacturing-agreement-with-canada/1975384


 


 



<< Previous
Bullboard Posts
Next >>